Publication:
Determination of CYP2C19 polymorphisms, adverse drug reaction, and medication adherence in patients utilized selective serotonin reuptake inhibitors

Simple item page
dc.contributor.authorDeniz, Semanur
dc.contributor.authorSANCAR, MESUT
dc.contributor.authorOKUYAN, BETÜL
dc.contributor.authorATA, PINAR
dc.contributor.authorBingol-Ozakpinar, Ozlem
dc.contributor.authorTALAS, Anil
dc.contributor.authorGUNES, Tufan
dc.contributor.authorCALISKAN, Mecit
dc.contributor.authorIzzettin, Fikret Vehbi
dc.contributor.institutionauthorİZZETTİN, FIKRET VEHBI
dc.date.accessioned2020-10-29T13:10:59Z
dc.date.available2020-10-29T13:10:59Z
dc.date.issued2015-02-01T00:00:00Z
dc.identifier.citationDeniz S., SANCAR M., OKUYAN B., ATA P., Bingol-Ozakpinar O., TALAS A., GUNES T., CALISKAN M., Izzettin F. V. , -Determination of CYP2C19 polymorphisms, adverse drug reaction, and medication adherence in patients utilized selective serotonin reuptake inhibitors-, INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, cilt.37, ss.231-232, 2015
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25111
dc.identifier.wosWOS:000349016600176
dc.titleDetermination of CYP2C19 polymorphisms, adverse drug reaction, and medication adherence in patients utilized selective serotonin reuptake inhibitors
dc.typeArticle
dspace.entity.typePublication
local.avesis.id0ad51f2c-6669-4763-8e87-129f6606f3d9
local.publication.isinternational1
relation.isAuthorOfPublicationcc4fb95b-daac-4065-9eea-9b57f6b44654
relation.isAuthorOfPublication.latestForDiscoverycc4fb95b-daac-4065-9eea-9b57f6b44654
Files
Collections
Yayınlar - Eserler